
Verve Therapeutics Inc
NASDAQ:VERV

Intrinsic Value
The intrinsic value of one
VERV
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 3.9 USD,
Verve Therapeutics Inc
is
hidden
.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Verve Therapeutics Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Verve Therapeutics Inc
Balance Sheet Decomposition
Verve Therapeutics Inc
Current Assets | 542.8m |
Cash & Short-Term Investments | 524.3m |
Receivables | 3.3m |
Other Current Assets | 15.2m |
Non-Current Assets | 104.6m |
PP&E | 96.7m |
Other Non-Current Assets | 7.9m |
Free Cash Flow Analysis
Verve Therapeutics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Verve Therapeutics Inc
Revenue
|
32.3m
USD
|
Operating Expenses
|
-261m
USD
|
Operating Income
|
-228.7m
USD
|
Other Expenses
|
30m
USD
|
Net Income
|
-198.7m
USD
|
VERV Profitability Score
Profitability Due Diligence
Verve Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Score
Verve Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.
VERV Solvency Score
Solvency Due Diligence
Verve Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Score
Verve Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
VERV Price Targets Summary
Verve Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
VERV
is 23.17 USD
with a low forecast of 15.15 USD and a high forecast of 33.6 USD.
Dividends
Current shareholder yield for VERV is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
VERV
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 3.9 USD,
Verve Therapeutics Inc
is
hidden
.